Stay updated on Cobimetinib in Relapsed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Cobimetinib in Relapsed Multiple Myeloma Clinical Trial page.

Latest updates to the Cobimetinib in Relapsed Multiple Myeloma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 added and v3.4.1 removed, with the government funding notice removed; no study data or core functionality is affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding and the NIH Clinical Center status, and updated the revision from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check28 days agoChange DetectedThe history view now includes a glossary option and shows color-coded change highlights (green for additions, red for deletions) along with the updated revision label (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check42 days agoChange DetectedA new revision entry, Revision: v3.3.4, was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe footer now shows Revision: v3.3.3, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check91 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cobimetinib in Relapsed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cobimetinib in Relapsed Multiple Myeloma Clinical Trial page.